CancerWorld #112 (February 2026)
Congratulations
conferences in the treatment of oncology
Prf Hesham ElGhazaly
Prf. Hesham ElGhazaly: Hosting the ASCO-ECS HCC Session during ASU-ICOC 2025
Prf. Hesham Elghazaly recognized among The 100 Most Influential People in Oncology in 2025
The agenda details a training session, likely focused on Hepatocellular Carcinoma (HCC), involving a mix of presentations and practical instruction.
Faculty of Medical AinShams Research Institute - 5 YEARS of Excellence
• 5 YEARS of Excellence
Current advances and future outlook of immunotherapy integration across early and late stage HCC
